Rudolf Magnus Institute of Neuroscience and Center of Excellence for Rehabilitation Medicine, University Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.
Rudolf Magnus Institute of Neuroscience and Center of Excellence for Rehabilitation Medicine, University Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.
Arch Phys Med Rehabil. 2014 Jan;95(1):87-93. doi: 10.1016/j.apmr.2013.08.236. Epub 2013 Sep 2.
To validate the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-Participation) in persons with spinal cord injury (SCI) using 2 International Classification of Functioning, Disability and Health (ICF)-based instruments: the ICF Measure of Participation and Activities-Screener (IMPACT-S) and the World Health Organization Disability Assessment Schedule II (WHODAS II).
Validation study. Score distributions, internal consistency, and concurrent and discriminant validity were evaluated.
The community.
Convenience sample of persons (N=157) with long-term SCI living in The Netherlands.
Not applicable.
USER-Participation, IMPACT-S, and WHODAS II.
No instruments showed floor effects, and 3 out of 6 WHODAS II domains showed ceiling effects. Most scores showed adequate internal consistency (α≥.70), except for the USER-Participation frequency scale (.51) and 2 WHODAS II domains (.58-.60). Spearman correlation coefficients between the segregate USER-Participation scales were <.60 (range, .39-.46), showing that they cover separate aspects of participation. Concurrent validity of the USER-Participation was shown because >75% (83.3%) of the 24 hypotheses (Spearman correlation coefficients above or below .60) with the other measurement instruments were confirmed. Concurrent validity between the IMPACT-S and WHODAS II was not shown (53.8% of 13 hypotheses confirmed). All scores except 4 WHODAS II domains showed significant differences in participation between persons with paraplegia and tetraplegia.
The USER-Participation showed generally satisfactory psychometric properties in Dutch persons with long-term SCI living in the community. The IMPACT-S showed the best psychometric properties, and the WHODAS II showed less favorable results. Future research on the USER-Participation should focus on validation in other languages and different diagnostic groups.
使用基于国际功能、残疾和健康分类(ICF)的两种工具,即参与和活动筛选器的 ICF 测量(IMPACT-S)和世界卫生组织残疾评估量表 II(WHODAS II),验证针对脊髓损伤(SCI)患者的乌得勒支康复参与量表(USER-Participation)。
验证性研究。评估了分数分布、内部一致性以及同时性和判别有效性。
社区。
157 名居住在荷兰的长期 SCI 患者的便利样本。
无。
USER-Participation、IMPACT-S 和 WHODAS II。
没有工具显示出地板效应,6 个 WHODAS II 领域中有 3 个显示出天花板效应。大多数分数表现出足够的内部一致性(α≥.70),除了 USER-Participation 频率量表(.51)和 2 个 WHODAS II 领域(.58-.60)。USER-Participation 分离量表之间的 Spearman 相关系数<60(范围,.39-.46),表明它们涵盖了参与的不同方面。USER-Participation 的同时有效性是因为与其他测量工具的 24 个假设(Spearman 相关系数高于或低于.60)中,有超过 75%(83.3%)得到了证实。IMPACT-S 和 WHODAS II 之间没有显示出同时有效性(13 个假设中有 53.8%得到证实)。除了 4 个 WHODAS II 领域外,所有分数都显示出截瘫和四肢瘫患者在参与方面的显著差异。
USER-Participation 在荷兰长期居住在社区的 SCI 患者中表现出总体令人满意的心理测量特性。IMPACT-S 表现出最好的心理测量特性,而 WHODAS II 则表现出不太有利的结果。未来对 USER-Participation 的研究应集中在其他语言和不同诊断组的验证上。